Report Detail
Global Diabetes Drugs Market Growth 2019-2024
- RnM2946607 |
- 15 February, 2019 |
- Global |
- 163 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Diabetes is a condition that keeps your body from making enough insulin. Insulin is a hormone that’s made by an organ called the pancreas. When the body doesn’t make enough insulin, sugar builds up in the blood instead of moving to cells and being used for energy. This causes blood sugar to be high. If blood sugar stays high for a long time, it can cause serious health problems – including blindness, kidney damage, heart disease and stroke. That’s why it’s important to take medicine that helps lower blood sugar levels. Diabetes can be managed so you can live a normal, healthy life.
All diabetes drugs work to lower the levels of sugar in the blood. There are two basic types of diabetes drugs: pills by mouth and shots injected into the skin. More than one drug is often needed to manage diabetes. Some people try different pills, take more than one pill, or take a pill along with shots.
As World overall economic downward trend in the past few years, and international economic situation is complicated, in the next few years there will be many uncertainties, coupled with diabetes drug industry in short supply on the market in the past few years, more companies will enter into the diabetes drug industry, the current demand for diabetes drug product is relatively high; comparing to the ordinary diabetes drug products selling on the market. Diabetes drug’s price remains in the same level as compared with the past years. The signal of market price change indicates the trend in the diabetes drug industry, the market still have large potential.
According to this study, over the next five years the Diabetes Drugs market will register a 5.4% CAGR in terms of revenue, the global market size will reach US$ 77900 million by 2024, from US$ 57000 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Diabetes Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Diabetes Drugs market by product type, application, key manufacturers and key regions and countries.
This study considers the Diabetes Drugs value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Sulphonylureas
Biguanides
Meglitinides
Thiazolidinediones
Alpha-glucosidase Inhibitors
DPP-4 Inhibitors
SGLT-2 Inhibitors
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Application I
Application II
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Sanofi
Novo Nordisk
MSD
Astrazeneca
Takeda
Novartis
North China Pharmaceutical Group Corporation
Huadong Medicine
Dongbao Pharmaceutical
Hisun Pharmacy
KELUN
Ginwa
Tianan Pharmaceutical
Jumpcan Pharmacy
Guangzhou Baiyun Mountain
SHIJIAZHUANG YILING PHARMACEUTICAL
Wanbang Biopharmaceuticals
Gan & Lee
Taloph
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Diabetes Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Diabetes Drugs market by identifying its various subsegments.
Focuses on the key global Diabetes Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Diabetes Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Diabetes Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Diabetes Drugs Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Diabetes Drugs Consumption 2014-2024
- 2.1.2 Diabetes Drugs Consumption CAGR by Region
- 2.2 Diabetes Drugs Segment by Type
- 2.2.1 Sulphonylureas
- 2.2.2 Biguanides
- 2.2.3 Meglitinides
- 2.2.4 Thiazolidinediones
- 2.2.5 Alpha-glucosidase Inhibitors
- 2.2.6 DPP-4 Inhibitors
- 2.2.7 SGLT-2 Inhibitors
- 2.3 Diabetes Drugs Consumption by Type
- 2.3.1 Global Diabetes Drugs Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Diabetes Drugs Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Diabetes Drugs Sale Price by Type (2014-2019)
- 2.4 Diabetes Drugs Segment by Application
- 2.4.1 Application I
- 2.4.2 Application II
- 2.5 Diabetes Drugs Consumption by Application
- 2.5.1 Global Diabetes Drugs Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Diabetes Drugs Value and Market Share by Application (2014-2019)
- 2.5.3 Global Diabetes Drugs Sale Price by Application (2014-2019)
3 Global Diabetes Drugs by Players
- 3.1 Global Diabetes Drugs Sales Market Share by Players
- 3.1.1 Global Diabetes Drugs Sales by Players (2017-2019)
- 3.1.2 Global Diabetes Drugs Sales Market Share by Players (2017-2019)
- 3.2 Global Diabetes Drugs Revenue Market Share by Players
- 3.2.1 Global Diabetes Drugs Revenue by Players (2017-2019)
- 3.2.2 Global Diabetes Drugs Revenue Market Share by Players (2017-2019)
- 3.3 Global Diabetes Drugs Sale Price by Players
- 3.4 Global Diabetes Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Diabetes Drugs Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Diabetes Drugs Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Diabetes Drugs by Regions
- 4.1 Diabetes Drugs by Regions
- 4.1.1 Global Diabetes Drugs Consumption by Regions
- 4.1.2 Global Diabetes Drugs Value by Regions
- 4.2 Americas Diabetes Drugs Consumption Growth
- 4.3 APAC Diabetes Drugs Consumption Growth
- 4.4 Europe Diabetes Drugs Consumption Growth
- 4.5 Middle East & Africa Diabetes Drugs Consumption Growth
5 Americas
- 5.1 Americas Diabetes Drugs Consumption by Countries
- 5.1.1 Americas Diabetes Drugs Consumption by Countries (2014-2019)
- 5.1.2 Americas Diabetes Drugs Value by Countries (2014-2019)
- 5.2 Americas Diabetes Drugs Consumption by Type
- 5.3 Americas Diabetes Drugs Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Diabetes Drugs Consumption by Countries
- 6.1.1 APAC Diabetes Drugs Consumption by Countries (2014-2019)
- 6.1.2 APAC Diabetes Drugs Value by Countries (2014-2019)
- 6.2 APAC Diabetes Drugs Consumption by Type
- 6.3 APAC Diabetes Drugs Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Diabetes Drugs by Countries
- 7.1.1 Europe Diabetes Drugs Consumption by Countries (2014-2019)
- 7.1.2 Europe Diabetes Drugs Value by Countries (2014-2019)
- 7.2 Europe Diabetes Drugs Consumption by Type
- 7.3 Europe Diabetes Drugs Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Diabetes Drugs by Countries
- 8.1.1 Middle East & Africa Diabetes Drugs Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Diabetes Drugs Value by Countries (2014-2019)
- 8.2 Middle East & Africa Diabetes Drugs Consumption by Type
- 8.3 Middle East & Africa Diabetes Drugs Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Diabetes Drugs Distributors
- 10.3 Diabetes Drugs Customer
11 Global Diabetes Drugs Market Forecast
- 11.1 Global Diabetes Drugs Consumption Forecast (2019-2024)
- 11.2 Global Diabetes Drugs Forecast by Regions
- 11.2.1 Global Diabetes Drugs Forecast by Regions (2019-2024)
- 11.2.2 Global Diabetes Drugs Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Diabetes Drugs Forecast by Type
- 11.8 Global Diabetes Drugs Forecast by Application
12 Key Players Analysis
- 12.1 Sanofi
- 12.1.1 Company Details
- 12.1.2 Diabetes Drugs Product Offered
- 12.1.3 Sanofi Diabetes Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Sanofi News
- 12.2 Novo Nordisk
- 12.2.1 Company Details
- 12.2.2 Diabetes Drugs Product Offered
- 12.2.3 Novo Nordisk Diabetes Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Novo Nordisk News
- 12.3 MSD
- 12.3.1 Company Details
- 12.3.2 Diabetes Drugs Product Offered
- 12.3.3 MSD Diabetes Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 MSD News
- 12.4 Astrazeneca
- 12.4.1 Company Details
- 12.4.2 Diabetes Drugs Product Offered
- 12.4.3 Astrazeneca Diabetes Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Astrazeneca News
- 12.5 Takeda
- 12.5.1 Company Details
- 12.5.2 Diabetes Drugs Product Offered
- 12.5.3 Takeda Diabetes Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Takeda News
- 12.6 Novartis
- 12.6.1 Company Details
- 12.6.2 Diabetes Drugs Product Offered
- 12.6.3 Novartis Diabetes Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Novartis News
- 12.7 North China Pharmaceutical Group Corporation
- 12.7.1 Company Details
- 12.7.2 Diabetes Drugs Product Offered
- 12.7.3 North China Pharmaceutical Group Corporation Diabetes Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 North China Pharmaceutical Group Corporation News
- 12.8 Huadong Medicine
- 12.8.1 Company Details
- 12.8.2 Diabetes Drugs Product Offered
- 12.8.3 Huadong Medicine Diabetes Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Huadong Medicine News
- 12.9 Dongbao Pharmaceutical
- 12.9.1 Company Details
- 12.9.2 Diabetes Drugs Product Offered
- 12.9.3 Dongbao Pharmaceutical Diabetes Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Dongbao Pharmaceutical News
- 12.10 Hisun Pharmacy
- 12.10.1 Company Details
- 12.10.2 Diabetes Drugs Product Offered
- 12.10.3 Hisun Pharmacy Diabetes Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Hisun Pharmacy News
- 12.11 KELUN
- 12.12 Ginwa
- 12.13 Tianan Pharmaceutical
- 12.14 Jumpcan Pharmacy
- 12.15 Guangzhou Baiyun Mountain
- 12.16 SHIJIAZHUANG YILING PHARMACEUTICAL
- 12.17 Wanbang Biopharmaceuticals
- 12.18 Gan & Lee
- 12.19 Taloph
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Diabetes Drugs . Industry analysis & Market Report on Diabetes Drugs is a syndicated market report, published as Global Diabetes Drugs Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Diabetes Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
